BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
April 28, 2003
View Archived Issues
Cel-Sci receives SBIR grant to develop treatment for autoimmune myocarditis
Read More
Methods of inhibiting cancer metastasis using polypeptides targeting chemokine receptors
Read More
Novel IKK-2 inhibitors prepared and tested at Pharmacia
Read More
Pyrazole-based antiproliferative agents covered by Bayer patent
Read More
Beta3-adrenoceptor agonists and their use in obesity, diabetes, etc.
Read More
Antibacterial agents with RNase-based mechanism of action discovered at Message
Read More
Mitsubishi Pharma and Sanofi-Synthelabo present new TPK1 inhibitors for AD
Read More
Novel vitamin D3 analogues with utility in osteoporosis and other disorders under study at Roche
Read More
Novo Nordisk presents new DPP-IV inhibitors
Read More
Axcan responds to Salix's rejection of cash tender offer
Read More
Serono initiates phase I trial of beta-sheet breaker peptide for Alzheimer's disease
Read More
AVI-4020 completes preclinical testing
Read More
TTS-CD2 prolongs survival in NSCLC
Read More
Tostrex rebranded Fortigel
Read More
Cypher stent approved by FDA
Read More
FavId phase II study expanded
Read More
Genesis Research and EvoGenix collaborate on antiinflammatory discovery
Read More
DCVax-Direct Adjuvant Cancer Therapy shows positive results in mice
Read More
FDA lifts clinical hold on Skeletal Targeted Radiotherapy
Read More
IND filed for phase III bromfenac studies
Read More
Positive Visicol laxative study results announced
Read More
Phase III findings for Extina in seborrheic dermatitis to support NDA filing
Read More
INGN-241 effective in ovarian cancer in preclinical study
Read More
LymphoStat-B is biologically active in patients with SLE
Read More
Drotrecogin alfa (activated) reduces mortality and organ failure in severe sepsis
Read More
The effects of sPLA2 inhibitor on the survival rate of patients with severe sepsis
Read More
Merck discontinues development of lead PDE4 inhibitor
Read More